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Summary
Gene-editing technologies have made it feasible to create nonhuman primate models for human 
genetic disorders. Here, we report detailed genotypes and phenotypes of TALEN-edited MECP2 
mutant cynomolgus monkeys serving as a model for a neurodevelopmental disorder, Rett 
syndrome (RTT), which is caused by loss-of-function mutations in the human MECP2 gene. Male 
mutant monkeys were embryonic lethal, reiterating that RTT is a disease of females. Through a 
battery of behavioral analyses, including primate-unique eye-tracking tests, in combination with 
brain imaging via MRI, we found a series of physiological, behavioral, and structural 
abnormalities resembling clinical manifestations of RTT. Moreover, blood transcriptome profiling 
revealed that mutant monkeys resembled RTT patients in immune gene dysregulation. Taken 
together, the stark similarity in phenotype and/or endophenotype between monkeys and patients 
suggested that gene-edited RTT founder monkeys would be of value for disease mechanistic 
studies as well as development of potential therapeutic interventions for RTT.
Graphical abstract
TALEN-edited MeCP2 mutant monkeys share phenotypes with Rett syndrome patients, providing 
a valuable model for studying disease mechanisms and for the development of potential 
therapeutics.
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Introduction
Rett syndrome (RTT) is a progressive neurodevelopmental disorder that mostly manifests in 
girls with a morbidity rate of 1:10,000–1:15,000 (Amir et al., 1999). Almost 95% of RTT is 
believed to be caused by mutations of an X-linked gene methyl-CpG-binding protein 2 
(MECP2) (Rett, 1966; Amir et al., 1999; Schanen et al., 1998). MECP2 mutations are most 
often embryonic lethal for boys, except for very few, who are born with severe 
encephalopathy leading to death before 2 years of age (Schanen et al., 1998). RTT girls 
seem to have normal development for up to 6–18 months but manifest a series of symptoms 
associated with intellectual disability, loss of acquired language, and compromised 
cognitive, social, and motor skills, etc. (Hagberg et al., 1983).
As RTT is a monogenic disorder, genetic modification technologies have made it possible to 
develop animal models for further study. RTT animal models were first generated in mice 
and recently in rats (Chen et al., 2001; Guy et al., 2001; Stearns et al., 2007; Ricceri et al., 
2008; Yang et al., 2013; Veeraragavan et al., 2016). It is interesting that RTT-related 
neurological phenotypes mostly occur in adult male rodents, which is different from the 
human disease (Lombardi et al., 2015; Patterson et al., 2016; Chen et al., 2001; Glaze, 2004; 
Guy et al., 2001). It is therefore conceivable that gene-edited nonhuman primates (NHPs) 
would serve as a better choice for modeling genetic neurological disorders including RTT 
(Jennings et al., 2016). Although monkeys and humans are different in many ways given that 
evolution has separated the Old World primate lineage into different paths, NHPs, such as 
rhesus and cynomolgus monkeys, still share high levels of genetic, physiological, social 
behavioral, and CNS developmental similarities with humans, making them suitable for the 
study of neurodevelopmental disorders (Shultz et al., 2011; Izpisua Belmonte et al., 2015)
In a previous study, we reported the successful application of TALEN-mediated mutagenesis 
to produce MECP2 mutant monkeys (Liu et al., 2014), which opened up great opportunities 
for using monkey models to better understand RTT and to develop potential treatments for 
the disease. In this study, using the same technology, we generated additional MECP2 
mutants, from which we recapitulated embryonic lethality of mutant males and 
physiological and behavioral abnormalities of mutant females, including primate-unique eye 
tracking, which are seen with RTT patients. Moreover, brain imaging by MRI, MeCP2 
protein measurements by semiquantitative western blotting, and transcriptome profiling of 
peripheral blood all demonstrated that these phenotypes (and/or endophenotypes) of the 
MECP2 mutant monkeys were strikingly similar to RTT clinical manifestations, which can 
be used for disease mechanistic studies as well as development of potential therapeutic 
interventions for RTT.
Results
Generation of MECP2 Mutant Monkeys via TALENs
In our previous report, one live female mutant monkey and three spontaneously aborted male 
mutant fetuses were generated using TALENs (Liu et al., 2014). After that, we generated 
another six live monkeys (four female mutants and two non-affected wild-type [WT] males) 
and five spontaneously aborted fetuses (two male mutants, two female mutants, one non-
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affected WT female). The fact that all male mutant monkeys were embryonic lethal 
recapitulated the human disease (Chen et al., 2001; Guy et al., 2001) but different from 
Mecp2 knockout mice. In this study, we gathered all available animals, i.e., five female 
mutants and five spontaneously aborted male fetuses from 41 surrogate recipients, and 
carried out the following studies (Figures 1A and 1B; Table S1).
Mutations of the MECP2 gene from live monkeys and aborted fetuses were verified through 
T7EN1 cleavage, Sanger sequencing, and genome alignment. Live female mutants were 
further analyzed using Sanger sequencing of PCR-based clones from accessible tissues and 
compared with the reference for detection of missense, nonsense mutations, and/or indels on 
exon 3 of the MECP2 gene (Table S2 and Figures 1C–1F). Distributions and frequencies of 
mutations for the #1 female MECP2 mutation-carrying monkey (ID: 130958) can be found 
in the previous report (Liu et al., 2014). As for the other four newborn mutant females, 
mutations detected in placenta, blood, and skin were plotted in Figure 1C. All detected point 
mutations were plotted based on their positions and mutation rate in the entire targeted 351 
bp of exon III.
MeCP2 protein levels in tissues (placentae and fibroblasts) of live monkeys and in brains 
(cortices) of aborted fetuses were overall lower in mutants as compared with those for WT 
controls (Figure 1G). Reduction of protein levels is shown in all five mutant monkeys 
(Figure 1G, a and b). Since it is not feasible to sample from cerebral cortices from live 
female monkeys due to technical and ethical concerns, we only compared MeCP2 levels in 
cortices from aborted fetuses from mutants and WT monkeys. Data from aborted male 
monkeys' cerebral cortices showed substantial reductions in MeCP2 levels (Figure 1G, c), 
which indirectly suggested that brain MeCP2 levels were also likely to be reduced in live 
mutant female monkeys. These data support the previous report that MeCP2 is a key 
regulator for neural development, which affects brain functions and behaviors (Chen et al., 
2001).
Concerning potential off-target effects, we used a genome-wide TALEN off-target site 
prediction tool named TALENoffer (Grau et al., 2013; Liu et al., 2014). The statistical model 
of TALENoffer assumes that possible nucleotides on a target site can be traced from the 
repeat-variable di-residue of the corresponding repeat, which determines DNA binding 
specificity. Using a definite cutoff (TALENoffer score > −1.8) to define potential off-targets 
in the whole genome, a total of 41 exonic loci were predicted to be potential off-target sites 
(Table S3). The fragments of all the potential off-target loci from three pairs of TALENs 
were PCR amplified and subjected to Sanger sequencing. No mutations were found on these 
sites (Table S3). These data indicate that we did not detect off-target mutations on all 41 
potential off-target sites from the four new monkeys and 11 WT control monkeys (Table S3).
MRI and EKG
Non-invasive neuroimaging is a very useful approach to assist diagnosis and monitoring 
longitudinal disease progression over time, which is particularly suitable for neural 
developmental disorders including RTT (Bjure et al., 1997; Naidu et al., 2001). We used 
MRI scanning to measure global or regional structural changes in brains of MECP2 mutant 
monkeys. Similar MRI scanning has been done with RTT patients and reported (Bjure et al., 
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1997; Naidu et al., 2001; Carter et al., 2008). In our study, MRI scanning was conducted 
three times with the first scanning performed at 7–8 months after birth, the second at 15 
months, and the third at 20 months. A total of 60 subregions of each monkey's brain was 
segmented, and data were analyzed by both rank-sum test and false discovery rate (FDR) to 
correct for multiple comparisons. Mutant monkeys showed significantly reduced cortical 
gray matter (GM) volumes in 16 regions at least at one stage when compared to normal 
controls (Figure 2, a–j). Younger (8 months old) mutant monkeys had more cortical areas 
showing statistically significant reductions as compared to WT controls, whereas at the 20th 
month of age only bilateral occipital gyri, right inferior temporal gyrus, and right annectant 
gyrus displayed statistically significant reduction in volumes. In contrast, the difference in 
right annectant gyrus only became significant at the 20th month but not at younger ages 
(Figure 2, a–j). Widespread reductions in GM volumes of specific sub-cortical areas and 
region-specific white matter (WM) volumes were also apparent in MECP2 mutant monkeys 
(Figure 2, k–p). Total brain GM and WM volumes, as well as total cortical volumes, total 
cortical surface areas, and average cortical thicknesses, were consistently smaller (with mean 
values) at all time points (i.e., 8, 15, and 20 months) in mutant monkeys, compared with WT 
controls, but the differences did not reach statistical significance (Figure S1). When these 
parameters were measured in a regional-specific manner, statistically significant alterations 
in mutant monkeys could be observed (Figures S1 and S2). Given that all five MECP2 
mutant monkeys have different repertoires of MECP2 mutations, these results suggest that 
abnormal brain development in mutant monkeys, including reductions of subregional GM 
and WM volumes, specific cortical surface area, and cortical thickness, are likely due to 
MeCP2 deficiency. This is further supported by consistent abnormalities reported in 
previous MRI studies on human subjects with RTT (Naidu et al., 2001; Reiss et al., 1993; 
Carter et al., 2008; Subramaniam et al., 1997).
Abnormalities of electrocardiogram (EKG) records including QT interval (QTc) value and 
heart rate (HR) were found in patients (Neul et al., 2010). We tried EKG recording on five 
mutant monkeys and five WT controls. The data were analyzed by both Kolmogorov-
Smirnov test and one-way ANOVA (p > 0.05). We found that mutant monkeys exhibited 
lower HR and longer QTc (Figure 3), which resembled RTT patients.
In addition, to investigate whether MECP2 mutant monkeys have any differences in growth 
and development compared to age- and gender- matched WT controls, basic parameters 
including body weight, body length, head circumference, and biparietal diameter were 
measured every 3 months. There was no difference between mutants and WT monkeys in 
these parameters (Figure S3).
Behavioral Analyses
According to clinical diagnostic criteria for RTT (Hagberg et al., 2002; Neul et al., 2010; 
Katz et al., 2016), behavioral symptoms such as loss of acquired purposeful hand skills, loss 
of acquired spoken language, development of hand stereotype, inappropriate reactivity to 
environments, impaired locomotion, disruption in social interaction, social withdrawal, 
sleeping disorder, and reduced response to pain are often used to diagnose the disease before 
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genetic testing for MECP2 mutations. Based on aforementioned symptoms, we used a 
battery of behavioral assays to analyze the phenotype of MECP2 mutant monkeys.
Sleep pattern was classified into awake and asleep phases (including relaxed and transitional 
sleep). Frequency and duration will be an important index to evaluate the sleep pattern. 
Thus, we recorded and analyzed these two indexes in MECP2 mutants and WT control 
monkeys. The total awake durations of mutants were found to be significantly longer while 
the total sleep durations were shorter than those of WT controls (Figure 4A, a). Remarkably, 
sleep in mutants was more fragmented than that in control monkeys, with more bouts of 
awaking and sleep (Figure 4A, b–d). It seemed difficult for mutant monkeys to have a 
continuous and longer-hour sleep, which is similar to RTT patients with abnormal circadian 
rhythms as well as Mecp2 mutant mice (Li et al., 2015).
Pain Threshold Test—We examined monkeys' responses to heat stress and found that 
WT monkeys moved their feet frequently and constantly in response to rising temperatures, 
while mutants made no attempt to escape from the heating plate (Movie S1). When 
temperature rose further to certain threshold, both mutant monkeys and WT controls 
exhibited nocifensive behaviors involving withdrawal and/or licking of either hind- and/or 
forelimbs, but mutants had a higher threshold for pain sensation toward higher temperatures 
(Figure 4B, a).
Active avoidance test was conducted with a high decibel level noise (120 dB noise) that was 
used as a source to trigger fear responses in monkeys according to a previous report 
(Winslow et al., 2002). The mutant monkeys could hear the auditory stimuli (Movie S2), but 
they covered their ears and hid themselves in the corner of the cage rather than escaping as 
WT controls did when the noise was presented (Figure 4B, b, Movie S2). These behaviors 
are very similar to those found in RTT patients with retarded reactions (Neul et al., 2010) or 
in mouse models (Stearns et al., 2007).
Activity Levels Assessment—Monkeys were under 24-hr continuous monitoring for 
assessment of activity levels. Compared to WT controls, mutants showed no significantly 
lower levels of activity during the 24 hr monitoring (WT versus mutant: 19.412 versus 
16.522, p = 0.665). During light time (8:00–20:00), no significant difference was observed 
between mutants and WT controls in levels of activity (mutants versus WT = 30.504 versus 
37.920, p = 0.574), and there was also no significant difference in dark time (20:00–8:00) 
activities (mutants versus WT = 2.542 versus 0.906, p = 0.299) (Figure 4B, c).
Social interaction behaviors were video-recorded and analyzed to assess active interactions. 
In this test, we found that mutant monkeys exhibited less active social contact, less 
environmental exploration, but more stereotypical behaviors, compared to WT controls. 
Moreover, mutant monkeys did not show aggressive behaviors as WT controls did (Figure 
4B, d–g; Movies S3 and S4). These results demonstrated stark similarity between mutant 
monkeys and RTT patients.
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Eye-Tracking Patterns
Using primate-unique eye-tracking measures, five mutant female monkeys and five age- and 
gender-matched WT controls were assessed for social preferences (when presented with 
monkey faces versus objects) and emotional processing (when presented with monkey faces 
in different emotional states). Mutant monkeys exhibited a preference for socially weighted 
stimuli, as they spent more time looking at monkey faces than inanimate objects (Figure 5A; 
Movie S5). However, when presented faces with aggressive or submissive emotions versus 
neutral faces, the mutants showed less interest in emotionally charged expressions but 
preferred neutral faces, as compared with WT monkeys (Figure 5B; Movie S5). These 
results are consistent with eye-tracking features of RTT patients who show more interest in 
socially weighted stimuli but have difficulties recognizing emotional expressions (Hetzroni 
and Rubin, 2006; Djukic and McDermott, 2012).
Transcriptome of Peripheral Blood in MECP2 Mutant Monkeys and RTT Patients
Due to high-level expression of MECP2 in neuronal cells, RTT is mainly a nervous system 
disease. Nevertheless, RTT patients also have many peripheral symptoms including cardiac, 
pulmonary, muscle, bone, gastro-intestinal, and immune system abnormalities, which may or 
may not be a direct link to dysfunctions of the nervous system. The peripheral symptoms 
above could also arise from MeCP2 loss of function in peripheral tissues, because MeCP2 is 
also expressed in many non-neural cells including fibroblasts. Since peripheral blood from 
RTT patients is more easily accessible than other tissues, analyses of blood samples for 
biomarkers may facilitate diagnosis and/or serve as outcome measures for potential clinical 
interventions. We thus profiled blood transcriptomes of monkeys to uncover potential 
endophenotype or biomarkers. Through weighted gene coexpression network analyses 
(WGCNA) (Zhang and Horvath, 2005; Langfelder and Horvath, 2008), we isolated three 
interconnected gene modules/clusters, which were expressed at different levels between 
mutant and WT monkeys (Figure 6A). Module-trait correlation matrix demonstrated that 
these gene clusters were either downregulated (brown and blue modules) or upregulated 
(turquoise module) in MECP2 mutant animals with statistical significance (Figure 6B).
Gene ontology (GO) term enrichment of biological process revealed that genes in blue and 
brown modules were heavily associated with immune responses, which was downregulated 
in mutant monkeys. This indicates potential deficits in immune functions, which is 
associated with MECP2 deficiency. In contrast, genes involved in protein translation and 
RNA processing (turquoise module) were upregulated in mutants (Figures 6C–6H). To 
assess the similarity between mutant monkeys and RTT patients, we analyzed the blood 
transcriptome sequencing in humans from six patients and five healthy age-matched 
controls. RTT patients' blood samples also revealed modules that were either downregulated 
and associated with “immune functions” or upregulated and associated with “translation” 
and “RNA processing” (Figure S4). Moreover, we found a list of genes that showed similar 
changes in monkeys and human correlated with MECP2 deficiency (Figures 6I and 6J and 
S4). These gene expression changes could be potentially used as biomarkers for RTT.
Chen et al. Page 7
Cell. Author manuscript; available in PMC 2017 August 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Discussion
RTT is a genetic neurodevelopmental disorder, currently with no cure. A lack of good 
animal models could potentially contribute to the slow progress of better understandings of 
the disease and finding cures. Although MECP2 mutant male mice exhibit phenotypes that 
resemble some of the symptoms of RTT female patients, it has been difficult or impossible 
to model more sophisticated disease symptoms in rodents. For example, Mecp2 knockout 
rodents show “limb-clasping” phenotype, but this phenotype is shared by neurodegeneration 
conditions in mice, which is not characteristic for RTT. In contrast, monkey models showed 
complicated behavioral features, such as fragmented sleep, increased stereotypy, reduced 
active avoidance of noisy or heat stimuli, and reduced environmental exploration, all of 
which resemble symptoms of patients. These activities are not widely set up for detection in 
mouse models.
Some of the characteristics of RTT displayed only in monkey models include male 
embryonic lethality, social withdrawal, and eye-tracking features, which have never been 
reported in rodents. Also, MRI of mutant monkeys provided information on longitudinal 
changes of brain structures with time, which could be very helpful for dissecting 
mechanisms of RTT. Although it is difficult to use MRI in clinical settings to track early-
stage neurodevelopmental changes in patients, limited human RTT patient MRI data showed 
striking similarity with the monkey data and further attest to the validity of our monkey 
models. Obviously, longitudinal MRI studies in rodents will be close to impossible, and, 
even if they are done, the short lifespan and rapid brain development of rodents as well as 
dramatic differences in brain structures between human and rodents will potentially make 
rodent models even less compelling. Moreover, in peripheral blood transcriptome 
sequencing, the genetic changes of monkey models overlap with that of RTT patients, which 
could be important molecular indicators to reflect RTT.
This work is also different from a previous report on monkey models of MECP2 duplication 
syndrome (Liu et al., 2016). In that report, monkeys with overexpressed MECP2 were 
generated via virus-induced gain-of-function expression of exogenous MECP2, which shares 
little similarity in terms of disease mechanisms with RTT. The ectopic pan-neuronal 
expression of MECP2 transgene may generate ectopic phenotypes, which are different from 
clinical MECP2 duplication mutations, where increased MECP2 expression only happens in 
neurons that originally express the gene, as not all neurons express MECP2. MECP2 mutant 
monkeys in our case were generated through TALEN-mediated gene editing that induced 
MECP2 deficiency, which is believed to be direct cause for RTT and thus making it possible 
to study the disease mechanism.
Great progress in neuroscience has been made and will continue by studying rodents and 
other simpler species, or even directly by clinical cases. NHP research will surely not 
replace these approaches and should be considered only in cases in which monkeys are the 
best and only available models for research. It seems RTT is a typical case in which monkey 
models may serve as a great system to study the mechanism and progression of the disease 
and to deliver new and effective treatments, since brains of other species are just too 
dissimilar to human brains. Non-primate models certainly are not able to mimic the 
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sophisticated features of cognition, social interactions, etc. Our study showed that a valid 
monkey model might offer robust phenotype or endophenotype, which could be 
implemented as outcome measures in human clinical trials in the future to facilitate drug 
development.
Star★Methods
Detailed methods are provided in the online version of this paper and include the following:
Contact for Reagent and Resource Sharing
Further information and requests for reagents may be directed to and will be fulfilled by the 
Lead Contact, Yongchang Chen (chenyc@lpbr.cn).
Experimental Model and Subject Details
Monkey Studies—The cynomolgus monkey (Macaca fascicularis) facility in this study is 
accredited by AAALAC International and all experimental protocols were approved in 
advance by the Institutional Animal Care and Use Committee of Yunnan Key Laboratory of 
Primate Biomedical Research. The animals were housed in a controlled environment 
(temperature: 22 ± 1°C; humidity: 50% ±5% RH) with 12 hr light/ 12 hr dark cycle (lights 
on at 08:00 a.m.). All animals were given commercial monkey diet twice a day with tap 
water ad libitum and were fed fruits and vegetables once daily. During and after 
experiments, monkeys have been under careful veterinary oversight to ensure good health. 
They were never involved in previous procedures, and are drug and/or test naive.
Human Studies—Human subject research was approved by Department of Pediatrics at 
Peking University First Hospital. Subjects' written informed consent was obtained prior to 
any study procedures. Subject details can be found in Table S4.
Method Details
Generation of TALEN Induced MECP2 Knockout Cynomolgus Monkeys—
Procedures for superovulation, oocytes collection, intracytoplasmic sperm injection (ICSI), 
TALENs injection, and embryo transfer and pregnancy diagnosis are in accordance with 
previous report (Liu et al., 2014). In brief, thirty female cynomolgus monkeys aged 5-10 
with regular menstrual cycles were selected as oocyte donors for superovulation, which were 
intramuscular injected with rhFSH (Recombinant Human FSH, Gonal F, Laboratories 
Serono) for 8 days and then with rhCG (Recombinant Human Chorionic Gonadotropin alpha 
for Injection, Merck Serono) on day 9. Oocytes were collected by laparoscopic follicular 
aspiration (STORZ) 32-35 hr after rhCG administration. Mature oocytes were used to 
perform ICSI. After co-incubation of oocytes and spermatozoa for 8-10 hr, fertilization was 
confirmed for the presence of two pronuclei and two polar bodies. About 5 pl of 2 ng/ml 
TALEN-coding plasmids were mixed and injected in the cytoplasm of fertilized oocytes. 
Injected embryos were cultured in chemically defined protein-free hamster embryo culture 
medium-9 (HECM-9, Millipore) containing 10% fetal bovine serum (FBS, GIBCO) at 37°C 
in 5% CO2 to allow embryo development. The quality cleaved embryos at 2-cell to 
blastocyst were transferred into the oviduct of the matched recipient monkeys. Fourty-one 
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females were used as surrogate recipients for TALENs injected embryos, and typically, 2-3 
embryos were transferred for each transfer. The earliest pregnancies were diagnosed by 
ultrasonography about 20 days after embryo transfer. Aborted tissues of all available parts of 
body were collected and then either fixed in 4% Paraformaldehyde (PFA, Sigma-Aldrich) or 
quick frozen in liquid nitrogen and stored at −80°C. All live neonatal baby monkeys were 
fed by host mothers or nurtured manually.
Genomic Mutations Analyses—Tissues including placenta, umbilical cord, ear skin 
fibroblasts, peripheral blood were collected and digested in lysis buffer (10 μM Tris-HCl, 0.4 
M NaCl, 2 μM EDTA, 1% SDS and 100 μg/ml Proteinase K). The genomic DNA was 
extracted from lysate by phenol-chloroform recovered by alcohol precipitation. Genomic 
mutations of miscarried and live monkeys were identified by T7EN1 cleavage assay with T7 
Endonuclease (NEB) and Sanger sequencing as described previously (Liu et al., 2014). Age- 
and gender-matched WT controls were housed and fed together with mutants under the same 
ambient condition. PCR products with mutations detected by T7EN1 cleavage assay were 
sub-cloned into T vector (Takara). For each sample, colonies were picked up randomly and 
Sanger sequenced by M13-47 primer.
Off-targets Assay—The potential off-target sites were predicted using a genome-wide 
TALEN target site prediction tool named TALENoffer (Grau et al., 2013; Liu et al., 2014). 
The statistical model of TALENoffer assumes that the possible nucleotides on a target site 
can be traced from the repeat-variable di-residue of the corresponding repeat, which 
determines DNA binding specificity. Using a definite cutoff (TALENoffer score > −1.8) to 
define potential off-targets in the whole genome, a total of 41 exonic loci were predicted to 
be potential off-target sites. The fragments of all the potential off-target loci from 3 pairs of 
TALENs were PCR amplified, then subjected to Sanger sequencing.
Western Blotting—For western blotting analysis, fibroblasts from ear, brain, and placenta 
tissues were lysed, of which MeCP2 protein expression analyzed using GAPDH as an 
internal control for protein were loading. About 40 μg of lysate was mixed with 5 × loading 
buffer, boiled for 5 min and loaded onto 10% SDS-PAGE gels and transferred onto a PVDF 
membrane (Millipore). The membranes were blocked with 5% non-fat milk for 1 hr, and 
then incubated with primary antibodies (MeCP2, Cell Signaling Technology; GAPDH, 
Kangcheng) overnight at 4°C and subsequently for 1 hr at room temperature (25°C) with 
Goat Anti-Rabbit IgG Antibody, (H+L) HRP conjugate (Millipore) or Goat anti-Mouse IgG, 
(H+L) HRP conjugate (Millipore). The epitope was tested using Pierce ECL Western 
Blotting Substrate (Thermo Scientific).
MRI Scanning—Monkeys at three different stages (4 mutants at 8 months, 3 mutants at 15 
months and 20 months) were arranged for MRI analysis. In each stage, more than 10 age- 
and gender-matched WT monkeys (11 WT at 8 months, 12 WT at 15 months, and 11 WT at 
20 months) were included in the test. MR images were scanned using a Philips 3.0 Tesla 
MRI scanner. Before the scan, all animals were pre-anesthetized intramuscularly with 
ketamine hydrochloride (15 mg/kg; Gutian, China) and xylazine (1.5 mg/kg; Huamu, 
China). The sagittal 3D T1-weighted images were acquired using an inversion-recovery 
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prepared 3-D spoiled gradient echo (SPGR) pulse sequence. To quantitatively measure the 
brains of mutant and WT monkeys, T1-weighted MR images were processed in a double-
blind manner using an in-house developed computational pipeline. Specifically, all T1-
weighted images were skull-stripped, corrected for intensity in homogeneity and resampled 
to be an isotropic resolution (0.375 mm × 0.375 mm × 0.375 mm). Then, tissue 
segmentation of T1-weighted images into gray matter (GM), white matter (WM), and 
cerebrospinal fluid (CSF) was performed by a machine learning-based method, which is a 
state-of-the-art method for segmentation of the challenging developing brain (Wang et al., 
2015). After tissue segmentation, the non-cortical structures were masked and filled, and 
each brain was separated into left and right hemispheres. Next, for each hemisphere of each 
image, the inner cortical surface (GM-WM interface) and outer cortical surface (GM-CSF 
interface) were reconstructed by using a topology-preserving deformable surface method (Li 
et al., 2014). The cortical thickness of each cortical vertex was computed as the average 
value of the minimum distance from inner to outer surfaces and the minimum distance from 
outer to inner surfaces. The surface area of each vertex was computed as one-third the sum 
of areas of all triangles associated with that vertex on the central surface, which is the 
geometric average of the inner and outer surfaces. To parcellate the cortical regions of each 
image, the INIA19 template was nonlinearly aligned onto each image using diffeomorphic 
demons based on the tissue maps, and accordingly its corresponding cortical label map was 
propagated onto each image and its corresponding cortical surfaces. As the INIA19 template 
(Rohlfing et al., 2012) contains too many tiny regions in sub-cortex and white matter, which 
will lead to inaccurate measurements, to parcellate the sub-cortex and whiter matter into 
relatively large regions for each image, the UNC Primate Brain Atlas was nonlinearly 
aligned onto each image using diffeomorphic demons (Vercauteren et al., 2009) based on the 
tissue maps, and then its corresponding subcortical and white matter labels were propagated 
onto each image. For global measurement, the total GM volume, total WM volume, total 
cortical GM volume, total cortical surface area and average cortical thickness were 
computed for each image. For regional measurement, a total of 60 subregions of each 
monkey's brain was segmented and analyzed, the cortical volume, cortical surface area and 
average cortical thickness were computed for each cortical region. Note that cortical 
thickness and surface area, which jointly determine the cortical volume, has distinct 
biological mechanism and developmental patterns, thus allowing us better understanding the 
cortical changes in mutant monkeys. And the volume of each subcortical region and each 
WM region were also computed.
EKG Recording—The monkeys were randomized in a double-blind manner to obtain the 
EKG signals by SYMTOP biophysical recording system (UEA-41FZ, Symtop Instrument, 
China) with a sample rate of 1000 Hz. The standard 12-lead EKG was monitored and 
recorded for over 10 min on awake monkeys with spontaneous breathing. The heart rate 
(HR) and QT interval (QTc) were measured automatically. Corrected QTc was measured 
using the Bazett's correction formula (QTc = QT/SQRT (RR)) (Shah, 2002).
Sleep Pattern—Behaviors of 10 cynomolgus monkeys, including 5 mutants and 5 WT 
controls, were continuously video-recorded for 3 consecutive nights from 19:00 p.m. to 9:00 
a.m. The video system consists of 10 infrared video cameras and a hard disk video recorder. 
Chen et al. Page 11
Cell. Author manuscript; available in PMC 2017 August 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
One camera faces one cage, ensuring that the entire cage was visible. Behaviors were scored 
by three raters independently who were blind to the experimental design. Three behavioral 
states, awake, transitional and relaxed sleep were scored in 1 min epochs (Noser et al., 
2003). States lasting < 30 s were not considered, whereas states lasting between 30 and 59 s 
were rounded to 1 min. The animals were considered to be awake when locomotion 
occurred, or when over 3 times of body or limb movement occurred within 1 min while in 
sitting or lying position. Sleep was scored as transitional when 1 or 2 times of body or limb 
movement occurred within 1 min while in sitting position. During relaxed sleep, the animals 
always kept the head below the shoulders or bent backward with no body or limb 
movements when sitting. Relaxed sleep was also scored when the animal was lying 
immobile. Sleep duration consisted of all 1 min epochs scored as transitional or relaxed 
sleep. Sleep fragmentation was defined as the frequency of waking bouts lasting 1 min or 
longer per night.
Pain Threshold Test—An improved hot-plate method (Winslow et al., 2002) was used to 
determine differences in pain threshold between 5 MECP2 mutants and 5 WT monkeys. The 
method using slowly increasing thermal stimulus applied mostly to the skin of animal 
plantar surface (Alshahrani et al., 2012). The equipment consists of several components, 
including an aluminum plate (40 cm × 40 cm) with the heating system underneath and a 
Plexiglas observation chamber above (40 cm × 40 cm × 80 cm), one heat controlling unit, 
one video camera for behaviors recording and one foot switch for remote control of the unit. 
The aluminum plate is divided into four equal parts (10 cm × 10 cm) and each part has a 
thermometer in the center. Before testing, visually inspect the equipment to corroborate the 
chosen heating rates (e.g., 6°C /min), initial standby and final cut-off temperatures (e.g., 
25°C and 55°C, respectively). Afterward, the experimenters felt the equipment themselves. 
Withdraw the hand from the hot plate at the moment of pain perception. The temperature 
should not cause harm to the skin nor produce any later discomfort. Once the equipment is 
ready, the monkeys were gently placed into the Plexiglass observation chamber, which was 
on top of the heating plate. Each monkey was given 5 min to acclimate to the equipment. 
Once the animal felt comfortable in the observation chamber, the plate was heated by 
pressing the footswitch. When the monkey exhibited nocifensive behaviors involving 
withdrawal and/or licking of either hind- and/or fore-limb, the temperature was recorded 
according to the thermometer in which the monkey stayed. Each monkey was tested once 
daily at the same time of the day for 3 test sessions.
Active Avoidance Test—A modified version of active avoidance test was used to 
evaluate monkeys' fear responses to loud noise according to previously report (Winslow et 
al., 2002). The equipment consists of several components, which included two adjoining 
Plexiglas observation chambers (80 cm × 80 cm × 80 cm) connected by a tunnel (60 cm × 
40 cm × 20 cm), two high-pitch loudspeakers, a video camera for recording behaviors and a 
foot switch for remote control of the loudspeaker. Each monkey was tested once daily at the 
same time of the day for 3 test sessions, and the time spent escaping from the noise was 
recorded. During the test, each monkey was carried from the home cage in a transport cage, 
which was placed at the door of the chamber. The door was then opened and the monkey 
entered the chamber. Each monkey was given a maximum of 5 min to enter themselves 
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otherwise they were pushed into the chamber. Each monkey had 5 min to adapt to the 
chamber and learn to shuttle between two chambers. Then loud noises (120 dB) were 
presented in the chamber where monkeys stayed according to previous studies (Winslow et 
al., 2002). This would cause monkeys to either escape to the adjoining chamber or crouch in 
the start chamber covering their ears. The noise was stopped when the monkeys escaped to 
the other chamber. In order not to inflict harm to monkeys, the noise should not exceed 5 
min. The monkeys' responses to noise stimuli and the time spent to escape were analyzed.
Activity Levels Assessment—The Actical Physical Activity Monitors (Respironics, 
Pennsylvania, USA) used to monitor activity levels of free-moving monkeys (five mutant 
females and five age-matched WT females) are water resistant (IEC Standard 60529 IPX7), 
lightweight (16 g), and small (2.9 cm × 3.7 cm × 1.1 cm). The Actical monitor uses a single 
internal omni-directional accelerometer that senses motion in all direction, integrates the 
amplitude and frequency of detected motion and produces an electrical current varying in 
magnitude. Therefore, an increased intensity of motion produces an increase in voltage. 
Actical stores the information in the form of activity counts. Monkeys' ID, body weight and 
length information were put into the Actical (Software version 3.1.0) before test. The device 
was placed on the monkeys' waists with soft belts. The monitor was mounted in the same 
waist position in each monkey to ensure the consistency of obtained data. The activity data 
were collected at a sampling rate of 32 HZ and in epochs as short as 1 s. Each monkey was 
monitored for 3 days. Data were downloaded using the Actireader that was connected to the 
PC via an RS-232 serial cable, and was communicated with Actical devices using a short 
range telemetric link.
Social Interaction Test—The social interaction test is a simple test in which behaviors 
are video-recorded and analyzed to assess social deficits in mutant monkeys with their age- 
and gender- matched control monkeys. The measured behaviors include active social 
contact, environmental exploration, stereotypical behaviors, and aggressive behaviors. 
Active social contact is defined as initiating a play, sharing toys, grooming for others, sitting 
together (within another monkey's arms' reach or in contact), etc. Environmental exploration 
includes tactile exploration of the cage or environment and oral exploration of the cage or 
environment (Altmann, 1974). The stereotypical behaviors are defined as repetitive and 
consistent actions with no apparent purposes, including pacing (repetitive, ritualized 
movement usually involving circling the cage), digit sucking (sucking on a finger or toe), 
self-grasping (grabbing or holding onto part of their own body), rocking (a back and forth 
movement of the upper body with still feet), bouncing (jumping up and down on all four 
legs), cage shaking (any vigorous shaking of the cage), body spasms (a quick shake of the 
body), and lip-smacking (pursing the lips together and moving them to produce a smacking 
sound) (Altmann, 1974). Aggressive behaviors included a bite, slap, grab, stare threat, open-
mouth threat, chase, and forced displacement (Qin et al., 2015). Each monkey was recorded 
once daily at the same time (9:00-10:00) of the day for 3 test sessions. The recordings were 
simultaneously analyzed by 3 viewers using a standardized behavioral classification.
Eye Tracking—Eye tracking is a useful technique in assessing cognitive changes in Rett 
syndrome, and we used a Tobii Pro TX300 Eye Tracker (Tobii Technology AB, Danderyd, 
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Sweden) in this study. Eye tracking data were sampled at 300 Hz and shown on a 23-inch 
monitor (with a resolution of 1920 × 1080 pixels) (Simpson et al., 2016). Five mutant 
monkeys and 5 age- and gender-matched WT monkeys were included in this task. The 
monkeys were trained habituating themselves to sit in the primate chair and to restrict the 
head movement by a helmet that was made of high density Ethylene-vinyl acetate (EVA). 
The helmets were customized to fit with each monkey's head. Once the monkeys were 
acclimated to the experimental procedure, two consecutive tests including paired face-object 
preference test and paired emotional faces preference test (Figure 4A), were conducted with 
an interval of about one week. During the tests, the eye tracker was set in front of the 
monkeys, with a distance of about 69 cm away from the monkeys' eyes, and ambient light 
levels were reduced to diminish distraction. As the monkeys were relatively quiet in their 
adolescence, the water was not restricted in completing looking tasks with the consideration 
of animal welfare. We studied the monkeys' free viewing behavior, which represents an 
innate behavior and potentially better reflects the monkeys' social and emotional information 
processing functions. Before each test, each monkey was calibrated to Tobii Studio's two 
preset locations, and the audio cartoon symbols were also used as calibration points to attract 
the monkeys' attention. During paired face-object preference tests, 20 stimuli were presented 
to each monkey. Each stimulus consists of a monkey's neutral face and an object, which is 
familiar to the monkeys. Ten faces (from 7 monkeys) and 10 different objects composed the 
20 stimuli with counterbalanced location. Faces and objects were about 8.5 × 9° of visual 
angle and separated by 8.5°. During paired emotional faces preference test, 14 stimuli were 
presented to each monkey. Each stimulus composed of a pair of faces of the same monkey. 
The total stimuli consisted of 5 different monkeys, each posing two or three expressions. 
These expressions included 3 kinds of emotional stimuli: neutral-aggression, neutral-
submission and aggression- submission, which were presented with counterbalanced 
sequence. Stimuli were presented using Tobii Studio software (Tobii Technology AB, 
Danderyd, Sweden) and eye tracking data were sampled at 300 Hz. The monkey faces were 
chosen from PrimFace database (website: https://visiome.neuroinf.jp/primface). The left part 
and the right part of each stimulus, separated by the midline of the screen, are simply 
defined as two AOIs (area of interests), which represents the corresponding faces or objects. 
Looking counts and looking duration of different AOIs were summarized automatically by 
Tobii Studio software.
Peripheral Blood Collection, Library Preparation, Sequencing and WGCNA—
All six Chinese patients with Rett syndrome and five healthy children were recruited in 2015 
and 2016. All the patients were interviewed and diagnosed according to clinic diagnostic 
criteria and mutations of MECP2. A questionnaire including clinical manifestation, family 
reproductive history, etc. was filled by the parents after signing an informed consent. Ethical 
approval was obtained from Clinical Research Ethics Committee, Peking University First 
Hospital. Genomic DNA was extracted using standard methods from the peripheral blood 
leukocytes of RTT patients and their parents. MECP2 mutational analysis was performed 
using polymerase chain reaction (PCR). If no mutations were identified, the MLPA-P015 
probe (SALSA MLPA kit P015MECP2, MRC-Holland, Amsterdam, Holland) was used to 
detect large deletions or duplications. MLPA products were separated and analyzed using the 
ABI Prism 3100 Genetic Analyzer and Genescan software according to manufacturer's 
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recommendations. For human patients (5 healthy and 6 RTT) and monkeys (5 mutant and 9 
WT), peripheral blood of mutants and controls were collected intravenously. Globin 
transcripts were first depleted from total RNA using the GLOBINclear kit (Life 
Technologies) following the manufacturer's protocols. All sequenced libraries were prepared 
using the TruSeq RNA Library Prep Kit v2 (Illumina) and sequencing data were mapped to 
either human genome (Ensembl GRCh38.79) or monkey genome (Ensembl Mmul_1.79) 
using TopHat (v.2.0.12). A signed network was constructed using all genes that were 
differentially expressed between WT and mutant blood samples at a cutoff of log2 (FPKM) 
differences at 0.1 or higher. Soft power parameter was estimated and used to derive a 
pairwise distance matrix for selected genes using the topological overlap measure, and the 
dynamic hybrid cut method was used to detect clusters. The node centrality, defined as the 
sum of within-cluster connectivity measures, was used to rank genes for “hub-ness” within 
each cluster. Hub genes in each module were graphically depicted using VisANT 1.0.
Statistical Analyses—Data analysis was conducted using the SPSS version 19.0 software 
package (SPSS, Chicago, IL, USA). Western blotting image data were processed with 
ImageJ software. The normality of the behavioral data were analyzed by Kolmogorov-
Smirnov test. All the behavioral data (Kolmogorov-Smirnov tests: p > 0.05), except active 
avoidance behavior, environmental exploration, stereotypical behaviors and aggressive 
displays were normally distributed. One-way ANOVA was used to analyze the differences 
between mutant monkeys and WT monkeys in sleep pattern, pain threshold, and active 
social contact, and Wilcoxon's signed rank tests were used to analyze the active avoidance 
behavior, environmental exploration, stereotypical behaviors and aggressive displays. The 
measures of looking counts and looking duration were obtained from eye-tracking paradigm. 
The normality of eye tracking data were analyzed by Kolmogorov-Smirnov test, and they 
were normally distributed (p > 0.05). In the paired face-object preference test, the counts and 
duration of looking at monkey faces versus objects were determined and analyzed with one-
way ANOVA, and in the test of paired emotional faces preference, they were also evaluated 
with one-way ANOVA to compare mutant monkeys with WT monkeys. The interactions 
were further analyzed with two-way ANOVA. The normality of data for monkeys' growth 
and development, including body weight, head circumference, body length, and biparietal 
diameter, were also analyzed by Kolmogorov-Smirnov test, the results of which demonstrate 
that they were normally distributed (p > 0.05). And the data were further analyzed in 
separate 2 (groups: mutant versus WT) × 5 (time: 6 months, 9 months, 12 months, 15 
months and 18 months) repeated-measures ANOVAs, with time being the repeated-measure. 
The measurements of each region were analyzed by Rank Sum test, and multiple 
comparisons were performed with the false discovery rate (FDR) correction (Benjamini and 
Hochberg, 1995). The normality of data for heart rate and electrocardiogram were analyzed 
by Kolmogorov-Smirnov test (p > 0.05), and one-way ANOVA was used to compare mutant 
monkeys with WT monkeys. The alpha level was set at p = 0.05 and all p values were 
generated using two-sided tests. All data are presented as the mean ± SEM.
Data and Software Availability
For material sharing, monkeys' materials (such as blood, mRNA, or DNAs) are available and 
free for sharing. However, as for patients, samples in the study were limited and there are 
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few left for sharing. Further information and requests for raw data, analysis details, and 
DNA/RNA samples can be directed to and fulfilled in compliance with IACUC protocol 
requirements by Lead Contact Yongchang Chen (chenyc@lpbr.cn). The RNA-seq raw data 
for monkeys and patients can be shared freely, and have been deposited in a public 
repository and the accession numbers are listed as below.
The accession numbers for the RNA-seq data reported in this paper are in the Sequence 
Read Archive (SRA) database at the NCBI (SRA: SRP105312 and SRP105313). The RNA-
seq raw data of children reported in this paper have been deposited to the NCBI (SRA: 
SRP105312) (https://www.ncbi.nlm.nih.gov/Traces/study/?acc=SRP105312). The RNA-seq 
raw data of cynomolgus monkeys have been deposited to the NCBI (SRA: SRP105313) 
(https://www.ncbi.nlm.nih.gov/Traces/study/?acc=SRP105313).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Modeling Rett syndrome using TALEN-edited MECP2 mutant cynomolgus 
monkeys
• MECP2 mutations induce male lethality and females resembling RTT patients
• Phenotypes include brain developmental and complex behavioral 
abnormalities
• The model will facilitate the deciphering of RTT mechanisms and 
development of new interventions
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Figure 1. Generation of MECP2 Mutant Cynomolgus Monkeys via TALENs
(A) General outcomes of MECP2 mutations mediated by TALENs in monkeys.
(B) Conclusion of mutant and WT monkeys including alive founders and aborted fetuses.
(C) Sanger sequencing in placenta, skin, and umbilical cord indicated there were multiple 
mutations on exon 3 of MECP2 gene. All detected point mutations were plotted based on 
their positions and mutation rates in the entire 351 bp on exon 3. See also Table S2.
(D) T7EN1 cleavage analysis and mutations of the placenta and skin tissue of five alive 
female monkeys. Mutation rates of five female monkeys calculated from Sanger sequencing 
on exon 3 of MECP2 (a–e). From total clones sequenced, perfect match (WT) and mismatch 
(mutant) sequences were identified comparing with reference sequences and counted for 
calculating mutation rates (f). For more mutant information, see also Tables S1 and S2.
(E) T7EN1 cleavage analysis and mutations of the placenta and skin tissue of two alive male 
monkeys.
(F) Sanger sequencing further identified that the mutations happened at the targeted exon in 
an alive monkey's ear skin and blood.
(G) Comparison of protein levels between the mutants and WT controls via western blots. (a 
and b) Western blots and statistical analysis of MeCP2 protein expressions in lysate of 
placenta (a) and skin fibroblasts (b) from alive mutant monkeys and WT controls; (c) 
western blots and statistical analysis of cortices from aborted WT and mutant fetuses. 
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Western blot image data were averaged from five repeats with ImageJ software. Compared 
with WT monkeys (n = 3, relativeMeCP2 value is set as 100%), all of the mutant monkeys 
exhibited lower MeCP2 protein expression. For MeCP2 expression levels in placenta of 
monkeys #130958, 142002, 142004, 152004, and 152014 were 44.71%, 16.47%, 55.26%, 
54.28%, and 63.57%, respectively, lower than those in WT; in fibroblasts, the numbers were 
61.92%, 25.79%, 53.63%, 57.10%, and 9.46%, lower than WT. In the cortices, male 
monkeys Mut1 and Mut2 expressed MeCP2 at levels 51.36% and 54.74%, respectively, 
lower than WT (n = 3, relative MeCP2 value is set as 100%).
For off-target results, see also Table S3.
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Figure 2. Dynamic Changes of Cortical and Sub-cortical Volume Monitored by MRI Scanning
(A) Regional measurements on cortical volume in mutant monkeys showed significantly 
smaller values in several regions (A), including in bilateral parahippocampal gyrus at 8 
months, left lingual gyrus at 8 months, left occipital gyrus at 8, 15, and 20 months, right 
lateral orbital gyrus at 8 months, right inferior occipital gyrus at 8 months, right inferior 
temporal gyrus at 8 and 20 months, right occipital gyrus at 15 and 20 months, right 
annectant gyrus at 20 months, and right lingual gyrus at 20 months (a–j).
(B) Sub-cortical regional and white matter (WM) volumes measurements in mutant monkeys 
showed significantly smaller values in several regions, including in bilateral amygdala at 8 
months, right amygdala at 15 months, bilateral cingulate WM region at 8, 15, and 20 
months, and bilateral corpus callosum at 8, 15, and 20 months (k–p).
(C) Quantitative analysis for measurements of (A) and (B). Bars and error bars represent 
mean ± SEM of replicate measurements. nsp > 0.05, *p < 0.05 (rank-sum test). For more 
information and further analysis, see also Figures S1 and S2. General growth and 
development of mutants and WT monkeys were also monitored; for the result, see also 
Figure S3.
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Figure 3. The EKG of MECP2 Mutant and WT Monkeys
The heart rate (HR) and QTc of five mutants and five WT monkeys. The mean value of HR 
in mutants was lower than that in WT monkeys, while QTc measurements in mutants were 
significantly prolonged compared with WT monkeys. The normality of data for heart rate 
and electrocardiogram was analyzed by Kolmogorov-Smirnov test (p > 0.05), and one-way 
ANOVA was used to compare mutant monkeys with WT monkeys. f/m, frequencies per min. 
Bars and error bars represent mean ± SEM of replicate measurements. *p < 0.05 (one-way 
ANOVA).
Chen et al. Page 23
Cell. Author manuscript; available in PMC 2017 August 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. Behavioral Phenotypes of MECP2 Mutant Monkeys
(A) Sleep pattern. (a and b) The mean value of awake (a) and asleep (b) durations (minutes 
per night) of mutant and WT monkeys. Mutant monkeys were in a longer state of awake 
(mutants versus WT = 248.800: 213.467 min per night, p = 0.050) and a shorter state of 
asleep (mutants versus WT = 531.200: 566.533 min per night, p = 0.050) than WT monkeys, 
but the differences have no significance (p = 0.05). (c) Sleep fragment (frequencies per 
night). The data suggested the mutant monkeys had trouble sleeping, as referred from the 
substantial number of bouts compared with WT controls (mutants versus WT = 41.333: 
26.200 numbers per night, p = 0.018). (d) Video recording of an overnight alternation of 
sleep and wake of a random selected mutant and an age-matched WT monkey (12 hr from 
7:00 p.m. to 7:00 a.m.). The patterns indicated there were more frequent naps for the mutant 
monkey.
(B) Responses to environments. (a) Pain perception of mutants and WT monkeys. The 
mutants' retarded responses to heat indicated they had a higher threshold for pain than WT 
controls (mutants versus WT = 48.192: 45.037°C, p = 0.030). (b) Active avoidance to noise 
exhibited by mutants and WT. The mutant monkeys showed delayed responses to noise, as it 
took longer for mutants to escape than the WT controls did (mutants versus WT = 
124.067:1.267 s, p = 1.345 × 10−5). (c) Activity. Compared with WT control monkeys, 
mutants showed no significantly lower levels of activity during the 24 hr monitoring 
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(mutants versus WT = 16.522:19.412, p = 0.665). During light time (8:00–20:00), no 
significant difference was observed between mutants and WT controls in levels of activity 
(mutants versus WT = 30.504: 37.920, p = 0.574), and there was also no significant 
difference in dark time (20:00–8:00) activities (mutants versus WT = 2.542: 0.906,p = 
0.299). (d) Aggressive behaviors. Mutant monkeys exhibited no aggressive behaviors, which 
was significantly different from WT controls (mutants versus WT = 0:10.200 f/h, p = 7.772 
× 10–6). (e) Environmental exploration. Mutant monkeys exhibited less frequencies of 
environmental exploration than WT controls (mutants versus WT = 2.933: 12.800 f/h, p = 
0.035). However, no significant difference was found in duration of environmental 
exploration (mutants versus WT = 22.200: 112.867 s/h, p = 0.053). (f) Stereotypical 
behaviors. Mutant monkeys exhibited more stereotypical behaviors than WT controls not 
only in frequencies (mutants versus WT = 34.667: 2.933 f/h, p = 0.021) but also in duration 
(mutants versus WT = 423.600: 16.667 s/h, p = 0.009). (g) Social contact. Mutant monkeys 
exhibited less social contact than WT controls in both frequencies (mutants versus WT = 
17.267: 49.400 f/h, p = 0.001) and duration (mutants versus WT = 922.867: 1688.800 s/h, p 
= 0.037). All the behavioral tests above were conducted in five mutants and five age-
matched WT monkeys. The “f/h” means frequencies per hour, and the “s/h” means seconds 
per hour.
Bars and error bars represent mean ± SEM of replicate measurements. nsp > 0.05, *p < 0.05 
(sleep pattern, pain threshold, and active social contact, one-way ANOVA; active avoidance 
behavior, environmental exploration, stereotypical behaviors and aggressive displays, 
Wilcoxon's signed-rank tests). See also Movies S1, S2, S3, and S4.
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Figure 5. Eye-Tracking Patterns in MECP2 Mutants and WT Monkeys
(A) View patterns of mutants (n = 5) and WT control monkeys (n = 5) in paired face-object 
task and paired emotional faces task. (a) Flow chart of eye-tracking task. The apostrophe 
indicates more test cycles. (b) An example of looking at one paired object-face stimuli. (c) 
An example of looking at one paired emotional face stimuli. The looking circle with the 
number “1” at the center represents the first look at this image. Subsequent looking 
numbered two traces the location and order of the next looks. Looking duration was in 
proportion to the diameter of the looking circles.
(B) Eye-tracking pattern for face-object stimuli. (a) Lines show the differences between the 
two groups in preference of monkey faces or objects. The mutant monkeys preferred looking 
at monkey faces as compared to WT controls, including looking counts (F = 8.747, p = 
0.009, ηp2 = 0.353) and looking duration (F = 15.443, p = 0.001, ηp2 = 0.491). (b) 
Histograms show that differences between the two groups in looking counts and looking 
duration at monkey faces versus objects. No significant differences were found between two 
groups in looking counts, but the mutants spent more time looking at monkey faces than WT 
controls (F = 9.695, p = 0.014).
(C) Eye-tracking pattern for emotional faces, including aggression, submission, and neutral. 
(a) Lines show the differences between the two groups in preference of emotional charged 
faces. The mutant monkeys preferred looking at neutral faces compared with aggressive or 
submissive faces, but no significant differences were found between the two groups in both 
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looking counts (F= 1.730,p= 0.199, ηp2 = 0.126) and looking duration (F=2.307,p=0.121, 
ηp2 = 0.161). (b) Histograms show that differences between two groups in looking counts 
and looking duration at monkey emotional faces. The mutant monkeys looked fewer times at 
aggressive (F = 13.919, p = 0.006) and submissive faces (F = 10.714, p = 0.011), and shorter 
duration at aggressive (F = 8.473, p = 0.020) and submissive faces (F = 14.965,p = 0.005). 
When presented with neutral faces, no significant difference was observed between the two 
groups, including looking counts (F = 3.652,p = 0.092) and looking duration (F = 0.408, p = 
0.541). The measurements of looking counts and looking duration were obtained from eye-
tracking paradigm. Bars and error bars represent mean ± SEM of replicate 
measurements. nsp > 0.05, *p < 0.05 (two-way ANOVA for interaction test and one-way 
ANOVA for pairwise test). See also Movie S5.
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Figure 6. Gene-Network Modules Associated with MECP2 Mutations in Monkeys and Human 
via WGCNA
(A) WGCNA dendrogram shows expression of different gene modules in 11 blood samples 
from five mutant and six WT monkeys.
(B) Correlation matrix between each module in mutant versus WT traits.
(C and D) Hub-gene network in blue (C) and brown (D) modules, respectively. Sizes of the 
dots correlate with degrees of hubness. Purple highlights genes shared similar changes in 
RTT patients.
(E) Hub-gene network in the turquoise module. Orange highlights genes shared similar 
changes in RTT patients.
(F–H) GO biological process term enrichment of genes in blue (F), brown (G), and turquoise 
(H) modules, respectively.
(I and J) Expanded view of the shared down- (I) and up- (J) regulated genes expressions in 
monkey and human RTT blood samples versus controls. See also Figure S4.
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